华纳药厂：重酒石酸去甲肾上腺素注射液获批注册

Core Viewpoint - Warner Pharmaceuticals has received approval from the National Medical Products Administration for the registration certificate of its drug, Dexamethasone Injection, which is indicated for the treatment of acute hypotension and cardiac arrest [1] Group 1 - The approved product is a 4ml:8mg formulation of Dexamethasone Injection [1] - The drug has been classified as a Class 3 chemical drug and has passed the consistency evaluation [1]